Your browser doesn't support javascript.
loading
S100 Calcium Binding Protein Family Members Associate With Poor Patient Outcome and Response to Proteasome Inhibition in Multiple Myeloma.
Liu, Minxia; Wang, Yinyin; Miettinen, Juho J; Kumari, Romika; Majumder, Muntasir Mamun; Tierney, Ciara; Bazou, Despina; Parsons, Alun; Suvela, Minna; Lievonen, Juha; Silvennoinen, Raija; Anttila, Pekka; Dowling, Paul; O'Gorman, Peter; Tang, Jing; Heckman, Caroline A.
Affiliation
  • Liu M; Institute for Molecular Medicine Finland - FIMM, HiLIFE - Helsinki Institute of Life Science, iCAN Digital Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland.
  • Wang Y; Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Miettinen JJ; Institute for Molecular Medicine Finland - FIMM, HiLIFE - Helsinki Institute of Life Science, iCAN Digital Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland.
  • Kumari R; Institute for Molecular Medicine Finland - FIMM, HiLIFE - Helsinki Institute of Life Science, iCAN Digital Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland.
  • Majumder MM; Institute for Molecular Medicine Finland - FIMM, HiLIFE - Helsinki Institute of Life Science, iCAN Digital Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland.
  • Tierney C; Department of Hematology, Mater Misericordiae University Hospital, Dublin, Ireland.
  • Bazou D; Department of Biology, National University of Ireland, Maynooth, Ireland.
  • Parsons A; Department of Hematology, Mater Misericordiae University Hospital, Dublin, Ireland.
  • Suvela M; Institute for Molecular Medicine Finland - FIMM, HiLIFE - Helsinki Institute of Life Science, iCAN Digital Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland.
  • Lievonen J; Institute for Molecular Medicine Finland - FIMM, HiLIFE - Helsinki Institute of Life Science, iCAN Digital Cancer Medicine Flagship, University of Helsinki, Helsinki, Finland.
  • Silvennoinen R; Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center, University of Helsinki, Helsinki, Finland.
  • Anttila P; Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center, University of Helsinki, Helsinki, Finland.
  • Dowling P; Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center, University of Helsinki, Helsinki, Finland.
  • O'Gorman P; Department of Biology, National University of Ireland, Maynooth, Ireland.
  • Tang J; Department of Hematology, Mater Misericordiae University Hospital, Dublin, Ireland.
  • Heckman CA; Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Front Cell Dev Biol ; 9: 723016, 2021.
Article in En | MEDLINE | ID: mdl-34485305
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Risk_factors_studies Language: En Journal: Front Cell Dev Biol Year: 2021 Document type: Article Affiliation country: Finlandia Country of publication: Suiza
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Risk_factors_studies Language: En Journal: Front Cell Dev Biol Year: 2021 Document type: Article Affiliation country: Finlandia Country of publication: Suiza